β-Blocker Use in Pregnancy and the Risk for Congenital Malformations

Ann Intern Med. 2019 Jun 18;170(12):909-910. doi: 10.7326/L19-0157.

Authors

Brian T Bateman¹, Krista F Huybrechts¹, Sonia Hernandez-Diaz², Helle Kieler³, Helga Zoega⁴

Affiliations

¹ Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts (B.T.B., K.F.H.).
² Harvard T.H. Chan School of Public Health, Boston, Massachusetts (S.H.).
³ Karolinska Institutet, Stockholm, Sweden (H.K.).
⁴ University of New South Wales, Sydney, New South Wales, Australia (H.Z.).

PMID: 31207630
DOI: 10.7326/L19-0157

No abstract available

Publication types

Letter
Comment

MeSH terms

Adrenergic beta-Antagonists*
Antihypertensive Agents*
Cohort Studies
Female
Humans
Pregnancy

Substances

Adrenergic beta-Antagonists
Antihypertensive Agents